Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New PPARalpha and/or PPARgamma agonists in Biovitrum pipeline

July 24, 2003

Potential efficacy of topiramate in long-term treatment of obesity

July 24, 2003

Improved results described for topical AA-2500 testosterone gel in male hypogonadism

July 24, 2003

Recombinant human GH reported to induce changes in the lipid metabolism of HIV-infected patients

July 23, 2003

Glucokinase activators: a novel class of antidiabetic agents

July 23, 2003

Piperazine antidiabetic and antiobesity agents in Shionogi research pipeline

July 23, 2003

Novel PPAR agonists prepared and tested by Indian team

July 23, 2003

Akzo Nobel presents new androgenic agents

July 23, 2003

Akzo Nobel describes novel ERbeta antagonists in recent patent

July 23, 2003

Manufacturing approval granted for pitavastatin

July 23, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...